# Rofecoxib After Surgery in Treating Patients With Stage II or Stage III Colorectal Cancer

> **NCT00031863** · PHASE3 · COMPLETED · sponsor: **Cancer Research Campaign Clinical Trials Centre**

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** rofecoxib
- **PROCEDURE:** adjuvant therapy

## Key facts

- **NCT ID:** NCT00031863
- **Lead sponsor:** Cancer Research Campaign Clinical Trials Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-02
- **Primary completion:** —
- **Final completion:** 2007-09
- **Target enrollment:** — (—)
- **Last updated:** 2013-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00031863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00031863, "Rofecoxib After Surgery in Treating Patients With Stage II or Stage III Colorectal Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00031863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*